Gassert Chad's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Mar 22, 2022
- Accession no.
- 0001415889-22-003267
- Filed
- Mar 22, 2022
- Trade date
- Mar 18-21, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $275.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gassert ChadCIK 0001871002 | Officer (SVP - CORP. DEV. & STRATEGY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $27.15 | +$135,750 | 388,226 | Indirect | |
| Mar 21, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $27.87 | +$139,350 | 393,226 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.